Apixaban vs warfarin: rise of newer anticoagulant
Druggist
APRIL 29, 2021
Eliquis is still protected by patent rights in the UK, with exclusive availability rights until 2026 (IPO, 2021). . Apixaban stops the production of enzymes (chemicals) required for the production of fibrin , a compound (protein) that plays a role in the clotting of the blood. Patients who have cancer or receive chemotherapy.
Let's personalize your content